Umihiko Sawada

917 total citations
77 papers, 691 citations indexed

About

Umihiko Sawada is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Umihiko Sawada has authored 77 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pathology and Forensic Medicine, 21 papers in Oncology and 19 papers in Genetics. Recurrent topics in Umihiko Sawada's work include Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (12 papers) and CNS Lymphoma Diagnosis and Treatment (9 papers). Umihiko Sawada is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (12 papers) and CNS Lymphoma Diagnosis and Treatment (9 papers). Umihiko Sawada collaborates with scholars based in Japan, United States and India. Umihiko Sawada's co-authors include Tetsuo Yamazaki, Takashi Horie, Shin Aizawa, Yoshihiro Hatta, Toshiyuki Takagi, Ichiro Tsujino, Fumio Kodama, Jin Takeuchi, K Sawada and Shinobu Nakamura and has published in prestigious journals such as Blood, Annals of Oncology and American Journal of Kidney Diseases.

In The Last Decade

Umihiko Sawada

74 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Umihiko Sawada Japan 14 258 194 132 132 112 77 691
D. Fırat Türkiye 14 192 0.7× 153 0.8× 115 0.9× 144 1.1× 83 0.7× 46 680
Filiz Şen United States 16 213 0.8× 278 1.4× 112 0.8× 77 0.6× 163 1.5× 42 623
Sandra J. Casak United States 18 455 1.8× 148 0.8× 171 1.3× 109 0.8× 78 0.7× 32 1.0k
Byung Soo Kim South Korea 18 334 1.3× 142 0.7× 221 1.7× 77 0.6× 105 0.9× 70 816
Peter Kozuch United States 19 557 2.2× 135 0.7× 259 2.0× 103 0.8× 119 1.1× 42 1.1k
U Magrini Italy 12 379 1.5× 181 0.9× 63 0.5× 134 1.0× 211 1.9× 21 706
Vivek R. Sharma United States 14 193 0.7× 46 0.2× 125 0.9× 65 0.5× 94 0.8× 52 777
Hoo G. Chun United States 15 440 1.7× 87 0.4× 304 2.3× 70 0.5× 63 0.6× 31 821
Keisuke Aiba Japan 15 500 1.9× 149 0.8× 194 1.5× 40 0.3× 78 0.7× 71 992
Donald R. Fleming United States 13 345 1.3× 63 0.3× 196 1.5× 58 0.4× 71 0.6× 25 740

Countries citing papers authored by Umihiko Sawada

Since Specialization
Citations

This map shows the geographic impact of Umihiko Sawada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umihiko Sawada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umihiko Sawada more than expected).

Fields of papers citing papers by Umihiko Sawada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Umihiko Sawada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umihiko Sawada. The network helps show where Umihiko Sawada may publish in the future.

Co-authorship network of co-authors of Umihiko Sawada

This figure shows the co-authorship network connecting the top 25 collaborators of Umihiko Sawada. A scholar is included among the top collaborators of Umihiko Sawada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umihiko Sawada. Umihiko Sawada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sawada, Umihiko, et al.. (2023). Toxic megacolon in Clostridium difficile colitis. IDCases. 33. e01858–e01858. 1 indexed citations
3.
Fukushima, Masamichi, et al.. (2013). Primary central nervous system malignant lymphoma in a patient with rheumatoid arthritis receiving low-dose methotrexate treatment. British Journal of Neurosurgery. 27(6). 824–826. 14 indexed citations
4.
Hatta, Yoshihiro, Y. Uchino, Hiromichi Takahashi, et al.. (2011). Long-term follow-up of localized, primary gastric diffuse large B-cell lymphoma treated with rituximab and CHOP. Experimental and Therapeutic Medicine. 3(2). 304–308. 6 indexed citations
5.
Nakagawa, Yoshiko, Katsuhiro Miura, Tetsuo Yamazaki, et al.. (2010). A case of treatment-related myelodysplastic syndrome spontaneously resolved by drug discontinuance. International Journal of Hematology. 91(3). 530–533. 1 indexed citations
6.
Hayashino, Yasuaki, Kunihiko Matsui, Yoshinori Noguchi, et al.. (2006). Quality of care associated with number of cases seen and self-reports of clinical competence for Japanese physicians-in-training in internal medicine. BMC Medical Education. 6(1). 33–33. 8 indexed citations
7.
Hatta, Yoshihiro, Tetsuo Yamazaki, Jin Takeuchi, et al.. (2006). Pioglitazone inhibits the growth of human leukemia cell lines and primary leukemia cells while sparing normal hematopoietic stem cells. International Journal of Oncology. 29(2). 437–43. 36 indexed citations
8.
Hattori, Tomohiro, Yoshihiro Matsukawa, Masami Takei, et al.. (2005). Adult Kawasaki Disease Unrelated to Epstein-Barr Virus and Group A Streptococcus. Internal Medicine. 44(11). 1182–1184. 6 indexed citations
9.
Hatta, Yoshihiro, et al.. (2005). Pure Red Cell Aplasia and Myelofibrosis in B-cell Neoplasm. Journal of International Medical Research. 33(4). 460–466. 6 indexed citations
10.
Hatta, Yoshihiro, Megumi Tanaka, Yoshitaka Kaneita, et al.. (2003). Requirement of soluble factors produced by bone marrow stromal cells on the growth of novel established human myeloma cell line.. PubMed. 22(3). 631–7. 5 indexed citations
11.
Niitsu, Nozomi, Yoshio Honma, Kimiko Iijima, et al.. (2003). Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma. Leukemia. 17(1). 196–202. 20 indexed citations
12.
Kaneita, Yoshitaka, Shoko Yoshida, Naoko Ishiguro, et al.. (2001). Detection of reciprocal fusion 5′‐BCL6/partner‐3′ transcripts in lymphomas exhibiting reciprocal BCL6 translocations. British Journal of Haematology. 113(3). 803–806. 4 indexed citations
13.
Nakamura, Shôji, Akira Yokota, T. Yoshino, et al.. (2000). びまん性大細胞型B細胞リンパ腫(DLBCL)における血清可溶性インターロイキン2受容体(sIL-2R)レベル:重要な予後因子. Annals of Oncology. 11. 103. 2 indexed citations
14.
Kaneita, Yoshitaka, et al.. (2000). [Phenotypic classification of malignant lymphoma].. PubMed. 58(3). 586–90. 1 indexed citations
15.
Yokota, Akira, Shinji Nakamura, T. Yoshino, et al.. (1999). High levels of serum CD44 are correlated with poor prognosis in malignant lymphoma.. Blood. 94(10). 511. 1 indexed citations
16.
Sawada, Umihiko, et al.. (1995). [Long term remission following relapsed CNS lymphoma].. PubMed. 36(3). 227–9. 1 indexed citations
18.
OHKUMA, Akio, Jun Takeuchi, Jodi Murakami, et al.. (1982). [A remission case of Ph1 positive acute myeloid leukemia].. PubMed. 23(9). 1482–8. 2 indexed citations
19.
Sawada, Umihiko, et al.. (1981). In vitro interactions between thymocytes and hemopoietic precursor cells. Annals of Hematology. 42(1). 1–12. 3 indexed citations
20.
Sawada, Umihiko, et al.. (1978). Hemopoiesis on macrophage-coated cellulose acetate membranes (CAMS) in mice: an immunological study.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 6(8). 694–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026